AbbVie Inc. is 21.8x more valuable than Viatris Inc by market capitalization ($399.47 B vs $18.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTRS | ABBV |
|---|---|---|
| Market cap | $18.36 B | $399.47 B |
| US-listed rank | #647 | #28 |
| Revenue (latest FY) | $14.25B | $61.16B |
| Net income (latest FY) | $0.00 | $4.23B |
| Net margin | 0.0% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 519 | 1,008 |
AbbVie Inc. is 21.8x more valuable than Viatris Inc by market capitalization ($399.47 B vs $18.36 B).
In their latest fiscal years, Viatris Inc reported $14.25B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Viatris Inc and AbbVie Inc., or browse the full rankings.